DOCSLIB.ORG

Conserved 33-Kb Haplotype in the MHC Class III Region Regulates Chronic Arthritis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Conserved 33-Kb Haplotype in the MHC Class III Region Regulates Chronic Arthritis Conserved 33-kb haplotype in the MHC class III region regulates chronic arthritis Anthony C. Y. Yaua, Jonatan Tuncela, Sabrina Haaga, Ulrika Norina, Miranda Houtmanb, Leonid Padyukovb, and Rikard Holmdahla,c,1 aMedical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden; bRheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, SE-171 76, Stockholm, Sweden; and cSouthern Medical University, Guangzhou 510515, China Edited by Philippa Marrack, Howard Hughes Medical Institute, National Jewish Health, Denver, CO, and approved May 16, 2016 (received for review January 12, 2016) Genome-wide association studies have revealed many genetic loci and lymphotoxin-β (LTB) (10). However, so far there is no evi- associated with complex autoimmune diseases. In rheumatoid ar- dence that polymorphism in the MHC-III region really contributes thritis (RA), the MHC gene HLA-DRB1 is the strongest candidate to the pathogenesis in RA or in its associated animal models. predicting disease development. It has been suggested that other MHC-III is challenging to study because of its high gene density immune-regulating genes in the MHC contribute to the disease and extensive linkage disequilibrium (LD) (9). Animal models for risk, but this contribution has been difficult to show because of RA are attractive alternatives to human association studies for the strong linkage disequilibrium within the MHC. We isolated gene identifications because the use of these models not only genomic regions in the form of congenic fragments in rats to test overcomes genetic heterogeneity and reduces environmental whether there are additional susceptibility loci in the MHC. By effects but also allows the isolation of specific genetic regions to both congenic mapping in inbred strains and SNP typing in wild study their roles in RA in vivo (14–16). Rat arthritis models such rats, we identified a conserved, 33-kb large haplotype Ltab-Ncr3 in as pristane-induced arthritis (PIA) (17, 18), which meet many of the MHC-III region, which regulates the onset, severity, and chro- the criteria for the diagnosis of RA (19), have been used to nicity of arthritis. The Ltab-Ncr3 haplotype consists of five poly- reveal highly significant linkages to unique chromosomal re- morphic immunoregulatory genes: Lta (lymphotoxin-α), Tnf, Ltb gions, often a much smaller interval with far fewer genes than (lymphotoxin-β), Lst1 (leukocyte-specific transcript 1), and Ncr3 previously postulated for quantitative traits (16, 20, 21). (natural cytotoxicity-triggering receptor 3). Significant correlation We recently established a panel of recombinant strains in the in the expression of the Ltab-Ncr3 genes suggests that interaction MHC region to study the MHC association with T-cell selection of these genes may be important in keeping these genes clustered (22) and showed that RT1-B (the human ortholog is HLA-DQ)in together as a conserved haplotype. We studied the arthritis asso- MHC-II determines the onset and severity of PIA (21). Here, we ciation and the spliceo-transcriptome of four different Ltab-Ncr3 constructed a panel of recombinant strains in MHC-III to study haplotypes and showed that higher Ltb and Ncr3 expression, the association of MHC-III with arthritis on the DA (RT1av1) lower Lst1 expression, and the expression of a shorter splice var- background. By dissecting this gene-dense region, gradually nar- iant of Lst1 correlate with reduced arthritis severity in rats. Inter- rowing down the size of the arthritis-regulating quantitative trait estingly, patients with mild RA also showed higher NCR3 expression locus (QTL), we identified a conserved 33-kb MHC-III haplo- and lower LST1 expression than patients with severe RA. These data type comprising highly polymorphic, differentially expressed, and demonstrate the importance of a conserved haplotype in the regu- spliced genes that regulates the onset, severity, and chronicity of lation of complex diseases such as arthritis. autoimmune arthritis. arthritis | major histocompatibility complex | congenic mapping | Significance haplotype | inflammation The role of the MHC region has been a long-standing issue in he MHC, known as the HLA complex in humans, is the most chronic inflammatory diseases, such as rheumatoid arthritis, and Tgene-dense and polymorphic region in the human genome it has not been possible to identify the underlying specific poly- with strong associations to many autoimmune diseases (1, 2). morphism. Here, we provide evidence that some of the MHC One such example is rheumatoid arthritis (RA). RA is a chronic association must be explained by how closely linked genes – autoimmune inflammatory joint disorder affecting 0.5 1% of the operate together as haplotype blocks. We identified a conserved general population. The genetic association of RA is mainly with haplotype, Ltab-Ncr3, comprising five genes (lymphotoxin α and MHC polymorphism; non-MHC loci [more than 100 RA-risk β,Tnf, leukocyte-specific transcript 1,andnatural cytotoxicity- loci have been identified in genome-wide association studies triggering receptor 3) within MHC class III, regulating arthritis. We (GWAS)] contribute only to a minor extent (3, 4). found significant coexpression of the Ltab-Ncr3 genes, indicating Recently it has been suggested that six different amino acids in how these genes may work together as a haplotype. Further- HLA-DRB1, HLA-A, HLA-B, and HLA-DPB1 explain most of more, haplotype-specific differences in Ltab-Ncr3 gene expres- the MHC association with RA in seropositive patients (5, 6). In sion and alternative splicing correlate remarkably to susceptibility addition, independent genetic susceptibility for RA has been to arthritis. Our data show that a conserved haplotype within identified in the MHC class III (MHC-III) (7–10). MHC-III is a MHC class III regulates arthritis development. region sandwiched between MHC class I (MHC-I) and MHC class II (MHC-II) in humans. This region consists of many genes Author contributions: A.C.Y.Y., J.T., and R.H. designed research; A.C.Y.Y., J.T., S.H., and U.N. performed research; M.H. and L.P. provided and prepared human samples; A.C.Y.Y. with important immune functions encoding for complement and J.T. analyzed data; and A.C.Y.Y., J.T., S.H., M.H., L.P., and R.H. wrote the paper. proteins, cytokines, and heat-shock proteins. Many of these The authors declare no conflict of interest. MHC-III genes have been described as candidate genes in RA, This article is a PNAS Direct Submission. including a gene encoding for TNF (11), which now is a thera- 1To whom correspondence should be addressed. Email: [email protected]. peutic target in RA and other autoimmune diseases (12, 13). This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. Other candidate genes include allograft-inflammatory factor-1 (8) 1073/pnas.1600567113/-/DCSupplemental. E3716–E3724 | PNAS | Published online June 14, 2016 www.pnas.org/cgi/doi/10.1073/pnas.1600567113 Downloaded by guest on September 29, 2021 Results intervals in this 2.8-Mb region (Fig. 1). We mapped all the MHC PNAS PLUS Identification of a 33-kb Locus in MHC-III That Regulates the Onset congenic and subcongenic strains on the 2004 (Baylor 3.4/rn4) and Severity of Arthritis. We previously identified RT1-B in the assembly which, based on more than 70 widely dispersed SNP MHC-II region as a susceptibility locus for acute PIA and ex- and short tandem repeat (STR) markers as described in the cur- cluded a contribution of the classical MHC-Ia region (21). Al- rent and a previous study (22), offers more accurate annotation though rats of both the MHC congenic strain DA.1HR2, which of the region than the 2012 (RGSC 5.0/rn5) and 2014 (RGSC spans the entire MHC, and the MHC-II congenic strain DA.1HR61 6.0/rn6) assemblies. We assessed acute arthritis in these strains (Fig. 1) were less susceptible to PIA, we observed a small but re- and found that rats of the subcongenic strains DA.1HR7N, producible difference in arthritis protection between these two strains DA.1HR56, DA.1HR56T, DA.1HR56A, and DA.1HR56D de- from day 14 to day 25 (Fig. 2A) (21). This observation suggested veloped significantly milder acute arthritis than DA rats, having a putative second QTL in the nonclassical MHC-Ib and/or the MHC- lower disease score, reduced weight loss, and a delayed disease III region, which was confirmed with the recombinant strain onset, whereas rats of the subcongenic strains DA.1HR4, DA.1HR7, which carries a fragment from DA.1HR2 in the DA.1HR52C, DA.1HR56C, and DA.1HR56E were not pro- MHC-Ib/MHC-III region (Fig. 1 and Table 1). tected (Fig. 1 and Table 1). These results demonstrate the ex- To identify the underlying genetic regulation in DA.1HR7 istence of a 32.7-kb arthritis-regulating QTL in the MHC-III rats, we generated ten subcongenic strains spanning different region (3.655–3.713 Mb) comprising five genes, lymphotoxin-α GENETICS if1 Bat2 Lst1Ncr3 A RT1-CE1 Bat1 Atp6v1g2 Nfkbil1 Abhd16a Ly6g5c Ly6g6f Ng23 G7c G7a Skiv2l Dxo Stk19 C4a C4b Cyp21a1 Tnxa-ps1 Atf6b fkbpl Prrt1 RT1-Db2 RT1-CE10 Ddah2 Clic1 RT1-CE4 RT1-CE5 RT1-CE2 RT1-CE3 Tnf Ltb Lta Bat3 Apom G4 Gpank1 Csnk2b Ly6g5b Ly6g6c Ly6g6d Ly6g6e G6b Ddah2 Msh5 Hspa1b Hspa1a Neu1 Slc44a4 Ehmt2 Zbtb12 C2 Cfb Nelfe Gpsm3 RT1-Ba RT1-Bb RT1-DOb Tap2 Psmb8 Tap1 Psmb9 Agpat1 Rnf5 Ager Pbx2 Notch4 Btnl5 Btnl3a2 Btnl8 Btnl7 Tesb RT1-DMb RT1-DMa RT1-Ha RT1-DOa Rxrb Col11a2 Slc39a7 Hsd17b8 Ring1 RT1-A3 RT1-A2 RT1-A1 Ppt2 Egfl8 Btnl2 RT1-Da RT1-Db1 Brd2 Btnl3 MHC Ib MHC III MHC II MHCIa telomere 3.50 3.75 4.00 4.25 4.50 4.75 5.00 centromere 1.62 5.447 5.976 HR2* 4.315 4.403 4.815 4.834 HR7* HR83 4.047 4.103 4.274 4.301 4.815 4.830 HR7N* HR61* 3.655 3.658 4.583 4.629 HR4 HR62 3.845 3.864 HR52C 3.430 3.452 epytolpah HR56* 3.850 3.863 HR56T* RT1h 3.801 3.806 HR56A* HR56B 3.711 3.713 HR56D* HR56C 3.635 3.649 HR56E UR2 3.801 3.806 RT1u RT1u UR2A haplotype FR2 2.79 4.815 4.834 RT1f RT1f FR9 haplotype 3.736 3.957 FR5 Ltab-Ncr3 RT1-B Fig.
Load more

Recommended publications
  • Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
    Review Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation Chiara Rizzo 1, Giulia Grasso 1, Giulia Maria Destro Castaniti 1, Francesco Ciccia 2 and Giuliana Guggino 1,* 1 Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology Section, University of Palermo, Piazza delle Cliniche 2, 90110 Palermo, Italy; [email protected] (C.R.); [email protected] (G.G.); [email protected] (G.M.D.C.) 2 Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-091-6552260 Received: 30 April 2020; Accepted: 29 May 2020; Published: 3 June 2020 Abstract: Primary Sjogren Syndrome (pSS) is a complex, multifactorial rheumatic disease that mainly targets salivary and lacrimal glands, inducing epithelitis. The cause behind the autoimmunity outbreak in pSS is still elusive; however, it seems related to an aberrant reaction to exogenous triggers such as viruses, combined with individual genetic pre-disposition. For a long time, autoantibodies were considered as the hallmarks of this disease; however, more recently the complex interplay between innate and adaptive immunity as well as the consequent inflammatory process have emerged as the main mechanisms of pSS pathogenesis. The present review will focus on innate cells and on the principal mechanisms of inflammation connected. In the first part, an overview of innate cells involved in pSS pathogenesis is provided, stressing in particular the role of Innate Lymphoid Cells (ILCs). Subsequently we have highlighted the main inflammatory pathways, including intra- and extra-cellular players.
    [Show full text]
  • Recombinant Human NCR3/Nkp300 Protein
    Leader in Biomolecular Solutions for Life Science Recombinant Human NCR3/NKp300 Protein Catalog No.: RP00179 Recombinant Sequence Information Background Species Gene ID Swiss Prot Natural Cytotoxicity Triggering Receptor 3, NCR3, also known as NKp30, or CD337, Human 259197 O14931 is a natural cytotoxicity receptor. NKp30 is expressed on both resting and activated NK cells of the CD56dim, CD16+ subset that account for more that 85% of NK cells Tags found in peripheral blood and spleen. NKp30 is absent from the CD56bright, CD16- C-Fc & 6×His subset that constitutes the majority of NK cells in lymph node and tonsil, however, its expression is up-regulated in these cells upon IL-2 activation .NKp30 is a Synonyms member of the immunoglobulin superfamily and one of three existing natural 1C7;CD337;DAAP-90L16.3;LY117;MALS cytotoxicity-triggering receptors. NKp30 is a glycosylated protein and is thought to ;NCR3;NKp30 be selectively expressed in resting and activated natural killer cells. NKp30 is a stimulatory receptor on human NK cells implicated in tumor immunity, and is capable of promoting or terminating dendritic cell maturation. NCR3 may play a role in inflammatory and infectious diseases. Product Information Source Purification Basic Information HEK293 cells > 95% by SDS- PAGE. Description Recombinant Human NCR3/NKp300 Protein is produced by HEK293 cells Endotoxin expression system. The target protein is expressed with sequence (Leu19-Thr138) < 0.1 EU/μg of the protein by LAL of human NCR3/NKp300 (Accession #NP_001138938.1) fused with an Fc, 6×His tag method. at the C-terminus. Formulation Bio-Activity Lyophilized from a 0.22 μm filtered Measured by its binding ability in a functional ELISA.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Associated B Cell Lymphoma and Nasopharyngeal Carcinoma
    Contribution of tumour cell signalling and the microenvironment to the pathogenesis of EBV- associated B cell lymphoma and nasopharyngeal carcinoma BY MAHA IBRAHIM A thesis submitted to The University of Birmingham For the degree of DOCTOR OF PHILOSOPHY Institute of Cancer and Genomic Sciences College of Medical and Dental Sciences University of Birmingham May 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract In this thesis I have explored different components of the pathogenesis of several related EBV associated cancers. In the first part of the thesis I focus on the microenvironment of two of these cancers, nasopharyngeal carcinoma (NPC) and diffuse large B cell lymphoma (DLBCL). Our group has developed a therapeutic vaccine against EBV which has already been shown to be safe in patients with NPC. Therefore, in the first results chapter (chapter 3), I present a description of the phenotyping of expression of the immune microenvironment including immune checkpoint (ICP) genes and MHC class I and class II genes in NPC tissues. I showed for the first time in NPC tissue samples, two types of PD-L1 expressing tumours: diffuse and marginal.
    [Show full text]
  • The Porcine Major Histocompatibility Complex and Related Paralogous Regions: a Review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman
    The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman To cite this version: Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman. The porcine Major Histocom- patibility Complex and related paralogous regions: a review. Genetics Selection Evolution, BioMed Central, 2000, 32 (2), pp.109-128. 10.1051/gse:2000101. hal-00894302 HAL Id: hal-00894302 https://hal.archives-ouvertes.fr/hal-00894302 Submitted on 1 Jan 2000 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Genet. Sel. Evol. 32 (2000) 109–128 109 c INRA, EDP Sciences Review The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick CHARDON, Christine RENARD, Claire ROGEL GAILLARD, Marcel VAIMAN Laboratoire de radiobiologie et d’etude du genome, Departement de genetique animale, Institut national de la recherche agronomique, Commissariat al’energie atomique, 78352, Jouy-en-Josas Cedex, France (Received 18 November 1999; accepted 17 January 2000) Abstract – The physical alignment of the entire region of the pig major histocompat- ibility complex (MHC) has been almost completed. In swine, the MHC is called the SLA (swine leukocyte antigen) and most of its class I region has been sequenced.
    [Show full text]
  • Supplementary Table S5. Differentially Expressed Gene Lists of PD-1High CD39+ CD8 Tils According to 4-1BB Expression Compared to PD-1+ CD39- CD8 Tils
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Immunother Cancer Supplementary Table S5. Differentially expressed gene lists of PD-1high CD39+ CD8 TILs according to 4-1BB expression compared to PD-1+ CD39- CD8 TILs Up- or down- regulated genes in Up- or down- regulated genes Up- or down- regulated genes only PD-1high CD39+ CD8 TILs only in 4-1BBneg PD-1high CD39+ in 4-1BBpos PD-1high CD39+ CD8 compared to PD-1+ CD39- CD8 CD8 TILs compared to PD-1+ TILs compared to PD-1+ CD39- TILs CD39- CD8 TILs CD8 TILs IL7R KLRG1 TNFSF4 ENTPD1 DHRS3 LEF1 ITGA5 MKI67 PZP KLF3 RYR2 SIK1B ANK3 LYST PPP1R3B ETV1 ADAM28 H2AC13 CCR7 GFOD1 RASGRP2 ITGAX MAST4 RAD51AP1 MYO1E CLCF1 NEBL S1PR5 VCL MPP7 MS4A6A PHLDB1 GFPT2 TNF RPL3 SPRY4 VCAM1 B4GALT5 TIPARP TNS3 PDCD1 POLQ AKAP5 IL6ST LY9 PLXND1 PLEKHA1 NEU1 DGKH SPRY2 PLEKHG3 IKZF4 MTX3 PARK7 ATP8B4 SYT11 PTGER4 SORL1 RAB11FIP5 BRCA1 MAP4K3 NCR1 CCR4 S1PR1 PDE8A IFIT2 EPHA4 ARHGEF12 PAICS PELI2 LAT2 GPRASP1 TTN RPLP0 IL4I1 AUTS2 RPS3 CDCA3 NHS LONRF2 CDC42EP3 SLCO3A1 RRM2 ADAMTSL4 INPP5F ARHGAP31 ESCO2 ADRB2 CSF1 WDHD1 GOLIM4 CDK5RAP1 CD69 GLUL HJURP SHC4 GNLY TTC9 HELLS DPP4 IL23A PITPNC1 TOX ARHGEF9 EXO1 SLC4A4 CKAP4 CARMIL3 NHSL2 DZIP3 GINS1 FUT8 UBASH3B CDCA5 PDE7B SOGA1 CDC45 NR3C2 TRIB1 KIF14 TRAF5 LIMS1 PPP1R2C TNFRSF9 KLRC2 POLA1 CD80 ATP10D CDCA8 SETD7 IER2 PATL2 CCDC141 CD84 HSPA6 CYB561 MPHOSPH9 CLSPN KLRC1 PTMS SCML4 ZBTB10 CCL3 CA5B PIP5K1B WNT9A CCNH GEM IL18RAP GGH SARDH B3GNT7 C13orf46 SBF2 IKZF3 ZMAT1 TCF7 NECTIN1 H3C7 FOS PAG1 HECA SLC4A10 SLC35G2 PER1 P2RY1 NFKBIA WDR76 PLAUR KDM1A H1-5 TSHZ2 FAM102B HMMR GPR132 CCRL2 PARP8 A2M ST8SIA1 NUF2 IL5RA RBPMS UBE2T USP53 EEF1A1 PLAC8 LGR6 TMEM123 NEK2 SNAP47 PTGIS SH2B3 P2RY8 S100PBP PLEKHA7 CLNK CRIM1 MGAT5 YBX3 TP53INP1 DTL CFH FEZ1 MYB FRMD4B TSPAN5 STIL ITGA2 GOLGA6L10 MYBL2 AHI1 CAND2 GZMB RBPJ PELI1 HSPA1B KCNK5 GOLGA6L9 TICRR TPRG1 UBE2C AURKA Leem G, et al.
    [Show full text]
  • What Is the Extent of the Role Played by Genetic Factors in Periodontitis?
    Perio Insight 4 Summer 2017 www.efp.org/perioinsight DEBATE EXPERT VIEW FOCUS RESEARCH Editor: Joanna Kamma What is the extent of the role played by genetic factors in periodontitis? Discover latest JCP research hile genetic factors are known to play a role in In a comprehensive overview of current knowledge, The Journal of Clinical Periodontology Wperiodontitis, a lot of research still needs to be they outline what is known today and discuss the (JCP) is the official scientific publication done to understand the mechanisms that are involved. most promising lines for future inquiry. of the European Federation of Indeed, the limited extent to which the genetic They note that the phenotypes of aggressive Periodontology (EFP). It publishes factors associated with periodontitis have been periodontitis (AgP) and chronic periodontitis (CP) may research relating to periodontal and peri- identified is “somewhat disappointing”, say Bruno not be as distinct as previously assumed because they implant diseases and their treatment. G. Loos and Deon P.M. Chin, from the Academic share genetic and other risk factors. The six JCP articles summarised in this Centre for Dentistry in Amsterdam. More on pages 2-5 edition of Perio Insight cover: (1) how periodontitis changes renal structures by oxidative stress and lipid peroxidation; (2) gingivitis and lifestyle influences on high-sensitivity C-reactive protein and interleukin 6 in adolescents; (3) the long-term efficacy of periodontal Researchers call regenerative therapies; (4) tooth loss in generalised aggressive periodontitis; (5) the association between diabetes for global action mellitus/hyperglycaemia and peri- implant diseases; (6) the efficacy of on periodontal collagen matrix seal and collagen sponge on ridge preservation in disease combination with bone allograft.
    [Show full text]
  • Fate Mapping Analysis of Lymphoid Cells Expressing the Nkp46 Cell Surface Receptor
    Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor Emilie Narni-Mancinellia,b,c,1, Julie Chaixa,b,c,1,2, Aurore Fenisa,b,c, Yann M. Kerdilesa,b,c, Nadia Yessaada,b,c, Ana Reyndersa,b,c, Claude Gregoirea,b,c, Herve Luchea,b,c, Sophie Ugolinia,b,c, Elena Tomaselloa,b,c, Thierry Walzera,b,c,3, and Eric Viviera,b,c,d,4 aCentre d’Immunologie de Marseille-Luminy, Université de la Méditerranée UM 631, Campus de Luminy Case 906, 13288 Marseille, France; bInstitut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 631, 13009 Marseille, France; cCentre National de la Recherche Scientifique, Unité Mixte de Recherche 6102, 13288 Marseille, France; and dAssistance Publique, Hôpitaux de Marseille, Hôpital de la Conception, 13385 Marseille, France Edited* by Christophe Benoist, Harvard Medical School, Boston, MA, and approved September 19, 2011 (received for review July 26, 2011) NKp46 is a cell surface receptor expressed on natural killer (NK) the selectivity of expression of eGFP in NDE mice mirrored that of cells, on a minute subset of T cells, and on a population of innate endogenous NKp46 in a fraction of transgenic mice, variegation at lymphoid cells that produce IL-22 and express the transcription the transgenic locus led to unpredictable variation in the pene- factor retinoid-related orphan receptor (ROR)-γt, referred to as NK trance of the transgene expression in mouse littermates. Another cell receptor (NKR)+ROR-γt+ cells. Here we describe Nkp46iCre knock- transgenic mouse expressing the improved Cre (iCre) recombinase in mice in which the gene encoding the improved Cre (iCre) recom- under the control of the Nkp46 promoter was recently reported binase was inserted into the Nkp46 locus.
    [Show full text]
  • Expression Profiling of Human Genetic and Protein Interaction Networks in Type 1 Diabetes
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Expression Profiling of Human Genetic and Protein Interaction Networks in Type 1 Diabetes Regine Bergholdt1*, Caroline Brorsson1, Kasper Lage2,3,4, Jens Høiriis Nielsen5, Søren Brunak2, Flemming Pociot1,6,7 1 Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark, 2 Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark, 3 Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 4 Broad Institute of MIT and Harvard, Seven Cambridge Center, Cambridge, Massachusetts, United States of America, 5 Department of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark, 6 University of Lund/Clinical Research Centre (CRC), Malmø, Sweden, 7 Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark Abstract Proteins contributing to a complex disease are often members of the same functional pathways. Elucidation of such pathways may provide increased knowledge about functional mechanisms underlying disease. By combining genetic interactions in Type 1 Diabetes (T1D) with protein interaction data we have previously identified sets of genes, likely to represent distinct cellular pathways involved in T1D risk. Here we evaluate the candidate genes involved in these putative interaction networks not only at the single gene level, but also in the context of the networks of which they form an integral part. mRNA expression levels for each gene were evaluated and profiling was performed by measuring and comparing constitutive expression in human islets versus cytokine-stimulated expression levels, and for lymphocytes by comparing expression levels among controls and T1D individuals.
    [Show full text]
  • Proteomics Analysis of Cellular Proteins Co-Immunoprecipitated with Nucleoprotein of Influenza a Virus (H7N9)
    Article Proteomics Analysis of Cellular Proteins Co-Immunoprecipitated with Nucleoprotein of Influenza A Virus (H7N9) Ningning Sun 1,:, Wanchun Sun 2,:, Shuiming Li 3, Jingbo Yang 1, Longfei Yang 1, Guihua Quan 1, Xiang Gao 1, Zijian Wang 1, Xin Cheng 1, Zehui Li 1, Qisheng Peng 2,* and Ning Liu 1,* Received: 26 August 2015 ; Accepted: 22 October 2015 ; Published: 30 October 2015 Academic Editor: David Sheehan 1 Central Laboratory, Jilin University Second Hospital, Changchun 130041, China; [email protected] (N.S.); [email protected] (J.Y.); [email protected] (L.Y.); [email protected] (G.Q.); [email protected] (X.G.); [email protected] (Z.W.); [email protected] (X.C.); [email protected] (Z.L.) 2 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun 130062, China; [email protected] 3 College of Life Sciences, Shenzhen University, Shenzhen 518057, China; [email protected] * Correspondence: [email protected] (Q.P.); [email protected] (N.L.); Tel./Fax: +86-431-8879-6510 (Q.P. & N.L.) : These authors contributed equally to this work. Abstract: Avian influenza A viruses are serious veterinary pathogens that normally circulate among avian populations, causing substantial economic impacts. Some strains of avian influenza A viruses, such as H5N1, H9N2, and recently reported H7N9, have been occasionally found to adapt to humans from other species. In order to replicate efficiently in the new host, influenza viruses have to interact with a variety of host factors. In the present study, H7N9 nucleoprotein was transfected into human HEK293T cells, followed by immunoprecipitated and analyzed by proteomics approaches.
    [Show full text]
  • Natural Killer Cell Lymphoma Shares Strikingly Similar Molecular Features
    Leukemia (2011) 25, 348–358 & 2011 Macmillan Publishers Limited All rights reserved 0887-6924/11 www.nature.com/leu ORIGINAL ARTICLE Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic cd T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro J Iqbal1, DD Weisenburger1, A Chowdhury2, MY Tsai2, G Srivastava3, TC Greiner1, C Kucuk1, K Deffenbacher1, J Vose4, L Smith5, WY Au3, S Nakamura6, M Seto6, J Delabie7, F Berger8, F Loong3, Y-H Ko9, I Sng10, X Liu11, TP Loughran11, J Armitage4 and WC Chan1, for the International Peripheral T-cell Lymphoma Project 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA; 2Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA; 3Departments of Pathology and Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; 4Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA; 5College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA; 6Departments of Pathology and Cancer Genetics, Aichi Cancer Center Research Institute, Nagoya University, Nagoya, Japan; 7Department of Pathology, University of Oslo, Norwegian Radium Hospital, Oslo, Norway; 8Department of Pathology, Centre Hospitalier Lyon-Sud, Lyon, France; 9Department of Pathology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea; 10Department of Pathology, Singapore General Hospital, Singapore and 11Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, USA Natural killer (NK) cell lymphomas/leukemias are rare neo- Introduction plasms with an aggressive clinical behavior.
    [Show full text]
  • The Role and Assembly Mechanism of Nucleoprotein in Influenza a Virus
    ARTICLE Received 28 Sep 2012 | Accepted 8 Feb 2013 | Published 12 Mar 2013 DOI: 10.1038/ncomms2589 The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes Lauren Turrell1, Jon W. Lyall2, Laurence S. Tiley2, Ervin Fodor1 & Frank T. Vreede1 The nucleoprotein of negative-strand RNA viruses forms a major component of the ribonucleoprotein complex that is responsible for viral transcription and replication. However, the precise role of nucleoprotein in viral RNA transcription and replication is not clear. Here we show that nucleoprotein of influenza A virus is entirely dispensable for replication and transcription of short viral RNA-like templates in vivo, suggesting that nucleoprotein repre- sents an elongation factor for the viral RNA polymerase. We also find that the recruitment of nucleoprotein to nascent ribonucleoprotein complexes during replication of full-length viral genes is mediated through nucleoprotein–nucleoprotein homo-oligomerization in a ‘tail loop- first’ orientation and is independent of RNA binding. This work demonstrates that nucleo- protein does not regulate the initiation and termination of transcription and replication by the viral polymerase in vivo, and provides new mechanistic insights into the assembly and regulation of viral ribonucleoprotein complexes. 1 Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. 2 Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK. Correspondence and requests for materials should be addressed to F.T.V. (email: [email protected]). NATURE COMMUNICATIONS | 4:1591 | DOI: 10.1038/ncomms2589 | www.nature.com/naturecommunications 1 & 2013 Macmillan Publishers Limited.
    [Show full text]